Occupancy and mechanism in antibody-mediated neutralization of animal viruses.

Neutralization of virus infectivity by antibodies is an important component of immunity to several virus infections. Here, the immunochemical basis for the action of neutralizing antibodies, and what role their induction of conformational changes in the antigen might play, is reviewed. Theories of the mechanisms by which antibodies neutralize virus infectivity in vitro are also presented. The theoretical and empirical foundation of the hypothesis that viruses are neutralized by a single antibody per virion is critically reviewed. The relationship between antibody occupancy on virions and the mechanism of neutralization is explored. Examples of neutralization mediated through antibody interference with virus attachment and entry are discussed and test implications of refined theories of neutralization by antibody coating of virions are formulated.

[1]  W A Hendrickson,et al.  Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. , 2000, Structure.

[2]  A. Thomas,et al.  Relationship between poliovirus neutralization and aggregation , 1986, Journal of virology.

[3]  N. K. Jerne,et al.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation. , 1956, Journal of immunology.

[4]  P. Spear,et al.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate , 1989, Journal of virology.

[5]  M. Law,et al.  Antibody neutralization of the extracellular enveloped form of vaccinia virus. , 2001, Virology.

[6]  S. Groth,et al.  The Neutralization of Viruses , 1963 .

[7]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[8]  D. Burton,et al.  The antiviral activity of antibodies in vitro and in vivo , 2001, Advances in Immunology.

[9]  P. Nara,et al.  Human Immunodeficiency Virus (HIV)-Positive Sera Obtained Shortly after Seroconversion Neutralize Autologous HIV Type 1 Isolates on Primary Macrophages but Not on Lymphocytes , 2000, Journal of Virology.

[10]  J. Sodroski,et al.  Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization , 1997, Journal of virology.

[11]  S. Zolla-Pazner,et al.  Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6 , 2001, Journal of Virology.

[12]  D. Burton,et al.  Antibody and virus: binding and neutralization. , 2000, Virology.

[13]  C. Wohlfart,et al.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms , 1988, Journal of virology.

[14]  M. Roivainen,et al.  An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. , 1993, Virology.

[15]  R. Ruigrok,et al.  Mechanisms of rabies virus neutralization. , 1993, Virology.

[16]  R. Dulbecco,et al.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.

[17]  T. Marlovits,et al.  Structure of a Neutralizing Antibody Bound Monovalently to Human Rhinovirus 2 , 1998, Journal of Virology.

[18]  G. Schochetman,et al.  Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization. , 1981, Virology.

[19]  E. G. Westaway,et al.  A multi-hit model for the neutralization of animal viruses. , 1978, The Journal of general virology.

[20]  A. Mosser,et al.  Postabsorption neutralization of poliovirus , 1993, Journal of virology.

[21]  G. Schochetman,et al.  Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. , 1981, Science.

[22]  B. Chesebro,et al.  Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1 , 1994, Journal of virology.

[23]  N. Dimmock,et al.  Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition. , 2000, Virology.

[24]  D. Stuart,et al.  Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus , 1990, Nature.

[25]  J. Nelson,et al.  Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus , 1987, Journal of virology.

[26]  P. Stewart,et al.  Recent structural solutions for antibody neutralization of viruses. , 1997, Trends in microbiology.

[27]  N. Greenspan.  Affinity, complementarity, cooperativity, and specificity in antibody recognition. , 2001, Current topics in microbiology and immunology.

[28]  D. Burton,et al.  Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection? , 2000, Nature Medicine.

[29]  M. Mazanec,et al.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies , 1995, Journal of virology.

[30]  N. Dimmock,et al.  Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp 120: identification of a very early fusion-independent event as a neutralization target. , 1996, The Journal of general virology.

[31]  Q. Sattentau,et al.  Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.

[32]  R M Zinkernagel,et al.  How many specific B cells are needed to protect against a virus? , 1994, Journal of immunology.

[33]  J. Tomassini,et al.  Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments , 1989, Journal of virology.

[34]  N. Dimmock,et al.  Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited , 1992, Journal of virology.

[35]  B. Mandel.  Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. , 1976, Virology.

[36]  J. Spouge,et al.  Blocking of human immunodeficiency virus infection depends on cell density and viral stock age , 1991, Journal of virology.

[37]  B. Rombaut,et al.  Hit-and-run neutralization of poliovirus. , 1985, The Journal of general virology.

[38]  P. Klasse,et al.  Mechanisms of enveloped virus entry into animal cells , 1998, Advanced Drug Delivery Reviews.

[39]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[40]  C. Spenlehauer,et al.  Antibody-Mediated Neutralization of Primary Human Immunodeficiency Virus Type 1 Isolates: Investigation of the Mechanism of Inhibition , 2001, Journal of Virology.

[41]  J. Moore,et al.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1 , 1996, Journal of virology.

[42]  Sullivan Nj.  Antibody-mediated enhancement of viral disease. , 2001 .

[43]  N. Dimmock.  Mechanisms of neutralization of animal viruses. , 1984, The Journal of general virology.

[44]  Timothy S. Baker,et al.  Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon , 1996, Nature.

[45]  Q. Sattentau,et al.  Antibody neutralization of HIV-1 and the potential for vaccine design. , 1999, Immunology letters.

[46]  R. Webster,et al.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. , 1967, Journal of immunology.

[47]  R. Kettmann,et al.  Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1 , 1997, Journal of virology.

[48]  A. Trkola,et al.  Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex , 1997, Journal of virology.

[49]  Neil S. Greenspan,et al.  Defining epitopes: It's not as easy as it seems , 1999, Nature Biotechnology.

[50]  H. Koprowski,et al.  Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. , 1987, Virology.

[51]  R. Schooley,et al.  Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins , 1987, Journal of virology.

[52]  H. Greenberg,et al.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture , 1991, Journal of virology.

[53]  W. Britt,et al.  Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H , 1995, Journal of virology.

[54]  M. Chow,et al.  Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature , 1994, Journal of virology.

[55]  John P. Moore,et al.  Genetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development , 2001, Journal of Virology.

[56]  D. Stuart,et al.  The structure and function of a foot‐and‐mouth disease virus–oligosaccharide receptor complex , 1999, The EMBO journal.

[57]  Q. Sattentau,et al.  HIV-1 attachment: another look. , 1999, Trends in microbiology.

[58]  D. Stuart,et al.  Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. , 1999, Virology.

[59]  B. Mandel.  Neutralization of Animal Viruses , 1978, Advances in Virus Research.

[60]  M. Marsh,et al.  Role of CD4 endocytosis in human immunodeficiency virus infection , 1995, Journal of virology.

[61]  Wai-ming Lee,et al.  Antibody-Mediated Neutralization of Human Rhinovirus 14 Explored by Means of Cryoelectron Microscopy and X-Ray Crystallography of Virus-Fab Complexes , 1998, Journal of Virology.

[62]  D. Blaas,et al.  Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. , 1996, The EMBO journal.

[63]  Q. Sattentau,et al.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.

[64]  P L Stewart,et al.  Cryo‐EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization , 1997, The EMBO journal.

[65]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[66]  B. Trus,et al.  Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution. , 1998, Journal of molecular biology.

[67]  E. Domingo,et al.  Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding , 1997, Journal of virology.

[68]  S. Harrison,et al.  Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.

[69]  D R Burton,et al.  A model for neutralization of viruses based on antibody coating of the virion surface. , 2001, Current topics in microbiology and immunology.

[70]  M. Reitz,et al.  The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope , 1990, Journal of virology.

[71]  J. Zeuthen,et al.  Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody , 1990, Journal of virology.

[72]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[73]  J. Sodroski,et al.  Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus , 2000, Journal of Virology.

[74]  D. Montefiori,et al.  Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. , 1995, Journal of Immunology.

[75]  A. Prince,et al.  Kinetic studies on the neutralization reaction between Japanese encephalitis virus and antiserum. , 1963, Virology.

[76]  D. Blaas,et al.  Structural studies on antibody interacting with viruses. , 2001, Current topics in microbiology and immunology.

[77]  N S Greenspan,et al.  Complementarity, specificity and the nature of epitopes and paratopes in multivalent interactions. , 1995, Immunology today.

[78]  N. Dimmock,et al.  Hemagglutinin 1-Specific Immunoglobulin G and Fab Molecules Mediate Postattachment Neutralization of Influenza A Virus by Inhibition of an Early Fusion Event , 2001, Journal of Virology.

[79]  J. Moore,et al.  HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. , 1995, AIDS.

[80]  G. Schild,et al.  Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. , 1982, The Journal of general virology.

[81]  T S Baker,et al.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.

[82]  R. Rueckert,et al.  Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. , 1983, Virology.

[83]  C. Andrewes,et al.  Observations on Anti-Phage Sera. I: “The Percentage Law” , 1933 .

[84]  H. Robinson,et al.  Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody , 1992, Journal of virology.

[85]  J. Spouge,et al.  HIV requires multiple gp120 molecules for CD4-mediated infection , 1990, Nature.

[86]  P. Linsley,et al.  Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1 , 1988, Journal of virology.

[87]  J. Sodroski,et al.  Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies. , 1998, Virology.

[88]  R. Webster,et al.  Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase , 1968, Journal of virology.

[89]  G. van der Groen,et al.  Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells. , 2001, Virology.

[90]  A. Thomas,et al.  Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions. , 1985, The Journal of general virology.

[91]  J. Sodroski,et al.  Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change , 1994, Journal of virology.

[92]  M. Reitz,et al.  An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site. , 1993, Virology.

[93]  D. Scott,et al.  Immunoglobulin G3 from Polyclonal Human Immunodeficiency Virus (HIV) Immune Globulin Is More Potent than Other Subclasses in Neutralizing HIV Type 1 , 2001, Journal of Virology.

[94]  N. Dimmock,et al.  A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity. , 2001, The Journal of general virology.

[95]  R. Lamb,et al.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions , 1988, Journal of virology.

[96]  L. Kingsford,et al.  Effects of specific monoclonal antibodies on La Crosse virus neutralization: aggregation, inactivation by Fab fragments, and inhibition of attachment to baby hamster kidney cells. , 1991, Virology.

[97]  Q. Sattentau,et al.  Mechanisms of virus neutralization by antibody. , 2001, Current topics in microbiology and immunology.

[98]  Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization , 1997, The Journal of experimental medicine.

[99]  Darren W. Henderson,et al.  Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins , 1994, Journal of virology.

[100]  R M Zinkernagel,et al.  Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[101]  W. Kinch,et al.  Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity. , 1985, The Journal of general virology.

[102]  H. Raux,et al.  Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. , 1995, Virology.

[103]  R. Compans,et al.  Effect of the Cytoplasmic Domain of the Simian Immunodeficiency Virus Envelope Protein on Incorporation of Heterologous Envelope Proteins and Sensitivity to Neutralization , 2000, Journal of Virology.

[104]  Andrew N. Phillips,et al.  Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.

[105]  F. Burnet,et al.  Immunological Reactions of the Filterable Viruses , 1938, Nature.

[106]  J. Sodroski,et al.  Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.

[107]  D I Stuart,et al.  Structure of the complex of an Fab fragment of a neutralizing antibody with foot‐and‐mouth disease virus: positioning of a highly mobile antigenic loop , 1997, The EMBO journal.

[108]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[109]  N. Dimmock,et al.  A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event. , 1997, Virology.

[110]  T. Smith,et al.  Antibody interactions with rhinovirus: lessons for mechanisms of neutralization and the role of immunity in viral evolution. , 2001, Current topics in microbiology and immunology.

[111]  P. Colman,et al.  Shape and electrostatic complementarity at viral antigen-antibody complexes. , 2001, Current topics in microbiology and immunology.

[112]  Q. Sattentau,et al.  Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation , 1996, The Journal of experimental medicine.

[113]  C. Grewe,et al.  HIV: early virus-cell interactions. , 1990, Journal of acquired immune deficiency syndromes.

[114]  L. Kjellén.  A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. , 1985, The Journal of general virology.

[115]  K. Schønning,et al.  Stoichiometry of Monoclonal Antibody Neutralization of T-Cell Line-Adapted Human Immunodeficiency Virus Type 1 , 1999, Journal of Virology.

[116]  Q. Sattentau,et al.  Human Immunodeficiency Virus Type 1 Attachment to HeLa CD4 Cells Is CD4 Independent and gp120 Dependent and Requires Cell Surface Heparans , 1998, Journal of Virology.

[117]  N. Greenspan,et al.  Dimensions of antigen recognition and levels of immunological specificity. , 2001, Advances in cancer research.

[118]  Deborah Fass,et al.  Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.

[119]  D R Burton,et al.  Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.

[120]  W. Gerhard.  The role of the antibody response in influenza virus infection. , 2001, Current topics in microbiology and immunology.

[121]  A. Arvin,et al.  Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice , 1995, Journal of virology.

[122]  M Aguet,et al.  The role of antibody concentration and avidity in antiviral protection. , 1997, Science.

[123]  T. Spira,et al.  Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody , 1996, Journal of virology.

[124]  K. Wetz.  Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating. , 1993, Virology.

[125]  B. Wahrén,et al.  Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1. , 1996, The Journal of general virology.

[126]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[127]  J. Skehel,et al.  Structural studies on viral escape from antibody neutralization. , 2001, Current topics in microbiology and immunology.

[128]  E. Wimmer,et al.  Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization , 1983, Journal of virology.

[129]  N. Dimmock,et al.  Quantitative relationships between an influenza virus and neutralizing antibody. , 1987, Virology.

[130]  M. Mach,et al.  Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera , 1999, Journal of Virology.

[131]  P. Klasse.  Physico-chemical Analyses of the Humoral Immune Response to HIV-1 : Quantification of Antibodies , Their Binding to Viral Antigens and Neutralization of Viral Infectivity , 1997 .

[132]  H. Pereira,et al.  Role of adenovirus antigens in the induction of virus neutralizing antibody. , 1968, The Journal of general virology.